NISA INVESTMENT ADVISORS, LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 180 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$2,852
-22.7%
800.0%0.00%
Q2 2023$3,690
+46025.0%
80
-61.9%
0.00%
Q1 2023$8
-20.0%
2100.0%0.00%
Q4 2022$10
-99.9%
2100.0%0.00%
Q3 2022$8,000
-98.4%
210
-97.5%
0.00%
-100.0%
Q2 2022$509,000
+1541.9%
8,533
+1870.7%
0.00%
Q1 2022$31,000
-75.8%
433
-76.3%
0.00%
-100.0%
Q4 2021$128,000
-16.9%
1,829
+7.5%
0.00%0.0%
Q3 2021$154,000
-57.2%
1,702
-54.9%
0.00%
-50.0%
Q2 2021$360,000
-39.5%
3,772
-27.8%
0.00%
-50.0%
Q1 2021$595,000
-17.7%
5,2220.0%0.00%
-20.0%
Q4 2020$723,000
+366.5%
5,222
+177.0%
0.01%
+400.0%
Q3 2020$155,000
+355.9%
1,885
+333.3%
0.00%
Q2 2020$34,000
+100.0%
435
+13.0%
0.00%
Q1 2020$17,000
+41.7%
385
+35.1%
0.00%
Q4 2019$12,0000.0%2850.0%0.00%
Q3 2019$12,000
-14.3%
285
+32.6%
0.00%
Q2 2019$14,000
-6.7%
2150.0%0.00%
Q1 2019$15,000
+66.7%
2150.0%0.00%
Q4 2018$9,000
-43.8%
2150.0%0.00%
Q3 2018$16,000
-23.8%
215
-21.8%
0.00%
Q2 2018$21,000
+133.3%
275
+57.1%
0.00%
Q1 2018$9,000
-50.0%
175
-35.2%
0.00%
Q1 2017$18,000
-48.6%
270
-46.0%
0.00%
Q4 2016$35,0000.0%5000.0%0.00%
Q3 2016$35,000
+133.3%
500
+66.7%
0.00%
Q2 2016$15,000
-21.1%
3000.0%0.00%
Q1 2016$19,0003000.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q1 2019
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 519,119$40,605,0003.00%
First Light Asset Management, LLC 236,958$18,535,0002.16%
SECTOR GAMMA AS 108,734$8,505,0001.76%
Rock Springs Capital Management LP 646,841$50,596,0001.39%
Atika Capital Management LLC 79,000$6,180,0000.80%
Capital Impact Advisors, LLC 30,582$2,392,0000.80%
FEDERATED HERMES, INC. 4,080,359$319,166,0000.79%
Rhenman & Partners Asset Management AB 61,500$4,811,0000.52%
Ikarian Capital, LLC 73,500$5,749,0000.46%
Capital International, Inc./CA/ 477,858$37,378,0000.46%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders